glucose, (beta-d)-isomer has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basdeo, SA; Costelloe, L; Dungan, LS; Fletcher, JM; Higgins, SC; Kelly, PJ; Kinsella, K; Lonergan, R; Mills, KH; Sweeney, CM; Tubridy, N | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.
Topics: Adult; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-alpha; Interferon-beta; Interleukins; Male; Mice; Mice, Inbred Strains; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Th17 Cells; Toll-Like Receptors; Young Adult; Zymosan | 2011 |